{"pub": "breitbart", "url": "https://breitbart.com/news/second-ebola-vaccine-to-be-used-in-dr-congo-next-month", "downloaded_at": "2019-10-13 23:40:44.052980+00:00", "title": "Second Ebola vaccine to be used in DR Congo next month", "language": "en", "text": "Kinshasa (AFP) \u2013 Doctors will use a second Ebola vaccine from November in three eastern provinces in the Democratic Republic of Congo to fight the deadly virus, medical officials said Sunday.\n\n\u201cIt\u2019s time to use the new Ad26-ZEBOV-GP vaccine, manufactured by Johnson & Johnson\u2019s Belgian subsidiary,\u201d said Dr. Jean-Jacques Muyembe, who leads the national anti-Ebola operation in the DRC.\n\nIt will arrive in the eastern city of Goma, in North Kivu province, on October 18 and be used from the beginning of next month, he added.\n\nDRC\u2019s latest Ebola epidemic, which began in August 2018, has killed 2,144 people, making it the second deadliest outbreak of the virus, after the West Africa pandemic of 2014-2016.\n\nMuyembe said the communes of Majingo and Kahembe had been selected to receive the vaccine as they were considered the epicentres of the epidemic.\n\n\u201cWe will extend this vaccination to our small traders who often go to Rwanda to protect our neighbours,\u201d he added.\n\n\u201cIf it works well, we will expand vaccination in South Kivu and Ituri.\u201d\n\nDR Congo\u2019s eastern provinces of Ituri, North Kivu and South Kivu sit on the borders with Uganda, Rwanda and Burundi.\n\nThe Belgian laboratory will send a batch of 200,000 doses to neighbouring Rwanda and 500,000 doses in the DRC, Muyembe said.\n\nMore than 237,000 people living in active Ebola transmission zones have received a vaccination produced by the pharma company Merck Sharpe and Dohme since August 8, 2018.\n\nThe J&J vaccine had been rejected by DRC\u2019s former health minister Oly Ilunga, who cited the risks of introducing a new product in communities where mistrust of Ebola responders is already high.\n\nBut Ilunga\u2019s resignation in July appears to have paved the way for approval of the second vaccine. He currently faces charges that he embezzled funds intended for the fight against Ebola.\n\nIn his letter of resignation Ilunga said \u201cactors who have demonstrated a lack of ethics\u201d want to introduce a second vaccine, but did not elaborate.\n\nMuyembe, who took over the Ebola fight in the DRC in July, said \u201cThe Johnson & Johnson vaccine has the most science-based data.\u201d", "description": "Kinshasa (AFP) \u2013 Doctors will use a second Ebola vaccine from November in three eastern provinces in the Democratic Republic of Congo to fight the", "authors": [], "top_image": "https://media.breitbart.com/media/2019/10/wi/afp/13/a12fc7_health-workers-in-dr-congo-are-struggling-ebola-outbreak-in-east-country-640x335.jpg", "published_at": "2019-10-13"}